Globitair

China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates

South China Morning PostPeople's Republic of China

China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales. Net profit reached 2.46 billion yuan for the three months ended September 30, jumping 88.92 per cent year on year and exceeding the Bloomberg analyst consensus estimate of 2.38 billion yuan. Improving innovative drug sales and out-licensing revenue...

Read the full story at South China Morning PostOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about People's Republic of China